Jane Visvader, Geoff Lindeman, Dr James Whittle, Delphine Merino and François Vaillant (IMAGE)

Walter and Eliza Hall Institute

Jane Visvader, Geoff Lindeman, Dr James Whittle, Delphine Merino and François Vaillant

Caption

A new class of anti-cancer agents that target cancer cells' 'Achilles' heel' could help to supercharge breast cancer treatment, improving outcomes for some of the most aggressive types of breast cancer. A research team from the Walter and Eliza Hall Institute in Melbourne, Australia, found that combining anti-cancer compound S63845 with currently used cancer drugs was more effective in killing triple negative breast cancers and HER2-positive breast cancers. L-R: Professor Jane Visvader, Professor Geoff Lindeman, Dr James Whittle, Dr Delphine Merino and Dr François Vaillant

Credit

Walter and Eliza Hall Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.